In both AML and MDS myeloblasts, pATM inhibition caused inhibition of NF-κB (loss of nuclear p65), coupled to the inactivation of the IKK complex and the redistribution of NEMO from the nucleus to the cytoplasm. This evidence concerns the gene NFKB1 and myelodysplastic syndrome.